Genetic dissection of systemic lupus erythematosus

Current Opinion in Immunology

Volumn 11, Issue 6, 1999, Pages 701-707

  Wakeland, Edward K ^a   Wandstrat, Amy E ^a   Liu, Kui ^a   Morel, Laurence ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032706819     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00039-4     Document Type: Review

References (35)

1. Tsao B.P., Cantor R.M., Kalunian C., Chen C-J., Badsha H., Singh R., Wallace D.J., Kitridou R.C., Chen S., Shen N.et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest. 99:1997;725-731.
2. Harley J.B., Moser K.L., Gaffney P.M., Behrens T.W. The genetics of human systemic lupus erythematosus. Curr Opin Immunol. 10:1998;690-696. This paper provides a well-referenced review of genetic studies of SLE susceptibility in humans.
3. •].
4. •].
5. •] present whole-genome scans of separate collections of SLE-affected sib-pair families.
6. Morel L., Rudofsky U.H., Longmate J.A., Schiffenbauer J., Wakeland E.K. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1:1994;219-229.
7. Morel L., Tian X-H., Croker B.P., Wakeland E.K. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity. 11:1999;131-139. Data presented in this report demonstrate that susceptibility to lupus nephritis is impacted by allele-specific genetic interactions between genes enhancing and suppressing disease.
8. Morel L., Mohan C., Schiffenbauer J., Rudofsky U.H., Tian J., Longmate J., Wakeland E.K. Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm Genome. 10:1999;176-181.
9. Drake C.G., Babcok S.K., Palmer E., Kotzin B.K. Genetic analysis of the NZB contribution to lupus-like autoimmune disease. Proc Natl Acad Sci USA. 91:1994;4062-4065.
10. Kono D.H., Burlingame R.W., Owens D.G., Kuramochi A., Balderas R.S., Balomenos D., Theofilopoulos A.N. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA. 91:1994;10168-10172.
11. Merino R., Shibata T., De Kossodo S., Izui S. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/Mpj mice. Eur J Immunol. 19:1989;2131-2137.
12. Hogarth M.B., Slingsby J.H., Allen P.J., Thompson E.M., Chandler P., Davies K.A., Simpson E., Morley B.J., Walport M.J. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol. 161:1998;2753-2761.
13. Santiago M.L., Mary C., Parzy D., Jacquet C., Montagutelli X., Parkhouse R.M., Lemoine R., Izui S., Reininger L. Linkage of a major quantitative trait locus to Yaa gene-induced lupus-like nephritis in (NZW x C57BL/6)F1 mice. Eur J Immunol. 28:1998;4257-4267.
14. Ida A., Hirose S., Hamano Y., Kodera S., Jiang Y., Abe M., Zhang D., Nishimura H., Shirai T. Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW x BXSB) F1 mice. Eur J Immunol. 28:1998;2694-2703.
15. Morel L., Yu Y., Blenman K.R., Caldwell R.A., Wakeland E.K. Production of congenic mouse strains carrying SLE-susceptibility genes derived from the SLE-prone NZM/Aeg2410 strain. Mamm Genome. 7:1996;335-339.
16. Mohan C., Morel L., Yang P., Watanabe H., Croker B.P., Gilkeson G.S., Wakeland E.K. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest. 103:1999;1685-1695. This study presents data demonstrating that fatal lupus nephritis can be produced in normal B6 mice by the introduction of Sle1 and Sle3 from the NZM2410 lupus-prone mouse strain.
17. Dietrich W.F., Lander E.S., Smith J.S., Moser A.R., Gould K.A., Luongo C., Borenstein N., Dove W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell. 75:1993;631-639.
18. Morel L., Mohan C., Croker B.P., Tian X-H., Wakeland E.K. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol. 158:1997;6019-6028.
19. Mohan C., Alas E., Morel L., Yang P., Wakeland E.K. Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucelosomes. J Clin Invest. 101:1998;1362-1372.
20. Winchester R. Genetic susceptibility to systemic lupus erythematosus. Lahita R.G. Systemic Lupus Erythematosus. 1992;65-85 Churchill Livingstone, New York.
21. Mohan C., Morel L., Yang P., Wakeland E.K. Genetic dissection of SLE pathogenesis: Sle2 on murine chromosome 4 leads to B-cell hyperactivity. J Immunol. 159:1997;454-465.
22. Mohan C., Yu Y., Morel L., Yang P., Wakeland E.K. Genetic dissection of SLE pathogenicity: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol. 162:1999;6492-6502.
23. Cohen P.L., Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 9:1991;243-269.
24. Izui S., Merino R., Fossati L., Iwamoto M. The role of the Yaa gene in lupus syndrome. Int Rev Immunol. 11:1994;211-230.
25. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 19:1998;56-59. This study presents results demonstrating that C1q deficiencies mediate a loss in tolerance to chromatin antigens and lead to an increase in apoptotic cell bodies in diseased kidneys.
26. Bickerstaff M.C., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., Mitchell D.A., Cook H.T., Butler P.J., Walport M.J., Pepys M.B. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med. 5:1999;694-697. This study demonstrates the effect of deficiencies in Sap on immune tolerance to chromatin and demonstrates that Sap deficiency impacts the clearance of chromatin in vivo.
27. Cornall R.J., Cyster J.G., Hibbs M.L., Dunn A.R., Otibopy K.L., Clark E.A., Goodnow C.C. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity. 8:1998;497-508. This study demonstrates the cumulative effect of multiple quantitative decreases in B cell antigen-receptor (BCR) signal transduction molecules on the immune system and postulates that such effects may be responsible for polygenic models of immune dysregulation.
28. Clynes R., Dumitru C., Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science. 279:1998;1052-1054. This study characterizes the role of Fc receptors in mediating the development of inflammatory damage as a consequence of immune complex deposition in the kidney.
29. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., Ramsey-Goldman R., Peterson M.G.E., Kimberly R.P. FcgammaRIIA alleles are heritable risk factors for lupus nephritis in african americans. J Clin Invest. 97:1996;1348-1354.
30. Wu J., Edberg J.C., Redecha P.B., Bansal V., Guyre P.M., Coleman K., Salmon J.E., Kimberly R.P. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest. 100:1997;1059-1070.
31. Gibson A., Wu J., Edberg J.C., Kimberly R.P. Fcgamma receptor polymorphisms: insights into pathogenesis. Kammer G., Tsokos G.C. Lupus: Molecular and Cellular Pathogenesis. 1999;557-573 Human Press, Inc, Totowa, NJ, USA.
32. Parren P., Warmerdam P., Boeije J., Arts L., Westerdaal N., Vlug A., Capel P., Aarden L., van de Winkel J. On the interaction of IgG subclasses with the low affinity FcGammaIIA. J Clin Invest. 90:1992;1537-1546.
33. Nagata S., Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today. 16:1995;39-43.
34. Wu J., Wilson J., Xiang L., Schur P.H., Mountz J.D. Fas ligand mutation in a patient with systemic lupus erythematosus and lympho-proliferative disease. J Clin Invest. 98:1996;1107-1113.
35. Tsao B.P., Cantor R.M., Grossman J., Shen N., Teophilov N., Wallace D.C., Arnett F.C., Hartung K., Goldstein R., Kalunian K.et al. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest. 103:1999;1135-1140.